WELL Health Technologies (CVE:WELL) has been given a C$0.95 price target by equities research analysts at Eight Capital in a research note issued on Wednesday, BayStreet.CA reports. The brokerage presently has a “buy” rating on the stock. Eight Capital’s target price points to a potential upside of 43.94% from the stock’s current price.

Separately, Haywood Securities set a C$0.90 target price on WELL Health Technologies and gave the company a “buy” rating in a report on Friday, March 1st.

WELL stock traded down C$0.01 during midday trading on Wednesday, hitting C$0.66. The company had a trading volume of 90,850 shares, compared to its average volume of 127,892. The company has a debt-to-equity ratio of 26.61, a quick ratio of 7.86 and a current ratio of 8.30. WELL Health Technologies has a 52 week low of C$0.36 and a 52 week high of C$0.75. The company has a market capitalization of $60.22 million and a P/E ratio of -18.86.

WELL Health Technologies Company Profile

WELL Health Technologies Corp. owns and operates a portfolio of primary healthcare facilities. The company was formerly known as Wellness Lifestyles Inc and changed its name to WELL Health Technologies Corp. in July 2018. WELL Health Technologies Corp. is based in Vancouver, Canada.

Featured Article: How to Track your Portfolio in Google Finance

Receive News & Ratings for WELL Health Technologies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for WELL Health Technologies and related companies with MarketBeat.com's FREE daily email newsletter.